Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Nov;39(11):2484–2489. doi: 10.1128/aac.39.11.2484

Biogenesis of the mycobacterial cell wall and the site of action of ethambutol.

K Mikusová 1, R A Slayden 1, G S Besra 1, P J Brennan 1
PMCID: PMC162969  PMID: 8585730

Abstract

The effect of ethambutol (EMB) is primarily on polymerization steps in the biosynthesis of the arabinan component of cell wall arabinogalactan (AG) of Mycobacterium smegmatis. Inhibition of the synthesis of the arabinan of lipoarabinomannan (LAM) occurred later, and thus in the cases of AG and LAM, the polymerization of D-arabinofuranose apparently involves separate pathways. While the synthesis of these arabinans was normal in an EMB-resistant isogeneic strain, the addition of EMB to the resistant strain resulted in partial inhibition of the synthesis of the arabinan of LAM and the emergence of a novel, truncated form of LAM, indicating partial susceptibility of the resistant gene(s) and providing a new intermediate in the LAM biosynthetic sequence. A consequence of inhibition of AG arabinan biosynthesis is the lack of new sites for mycolate attachment and thus the channeling of mycolate residues into a variety of free lipids which then accumulate. The primary biochemical effects of EMB can be explained by postulating separate AG and LAM pathways catalyzed by a variety of extramembranous arabinosyl transferases with various degrees of sensitivity to EMB.

Full Text

The Full Text of this article is available as a PDF (868.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Besra G. S., Khoo K. H., McNeil M. R., Dell A., Morris H. R., Brennan P. J. A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy. Biochemistry. 1995 Apr 4;34(13):4257–4266. doi: 10.1021/bi00013a015. [DOI] [PubMed] [Google Scholar]
  2. Besra G. S., Sievert T., Lee R. E., Slayden R. A., Brennan P. J., Takayama K. Identification of the apparent carrier in mycolic acid synthesis. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12735–12739. doi: 10.1073/pnas.91.26.12735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brennan P. J., Nikaido H. The envelope of mycobacteria. Annu Rev Biochem. 1995;64:29–63. doi: 10.1146/annurev.bi.64.070195.000333. [DOI] [PubMed] [Google Scholar]
  4. Chatterjee D., Bozic C. M., McNeil M., Brennan P. J. Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis. J Biol Chem. 1991 May 25;266(15):9652–9660. [PubMed] [Google Scholar]
  5. Chatterjee D., Lowell K., Rivoire B., McNeil M. R., Brennan P. J. Lipoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains. J Biol Chem. 1992 Mar 25;267(9):6234–6239. [PubMed] [Google Scholar]
  6. Cohn M. L., Waggoner R. F., McClatchy J. K. The 7H11 medium for the cultivation of mycobacteria. Am Rev Respir Dis. 1968 Aug;98(2):295–296. doi: 10.1164/arrd.1968.98.2.295. [DOI] [PubMed] [Google Scholar]
  7. Deng L., Mikusová K., Robuck K. G., Scherman M., Brennan P. J., McNeil M. R. Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope. Antimicrob Agents Chemother. 1995 Mar;39(3):694–701. doi: 10.1128/AAC.39.3.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FOLCH J., LEES M., SLOANE STANLEY G. H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957 May;226(1):497–509. [PubMed] [Google Scholar]
  9. Hirschfield G. R., McNeil M., Brennan P. J. Peptidoglycan-associated polypeptides of Mycobacterium tuberculosis. J Bacteriol. 1990 Feb;172(2):1005–1013. doi: 10.1128/jb.172.2.1005-1013.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hunter S. W., Gaylord H., Brennan P. J. Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J Biol Chem. 1986 Sep 15;261(26):12345–12351. [PubMed] [Google Scholar]
  11. Kilburn J. O., Takayama K. Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis. Antimicrob Agents Chemother. 1981 Sep;20(3):401–404. doi: 10.1128/aac.20.3.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lederer E. The mycobacterial cell wall. Pure Appl Chem. 1971;25(1):135–165. doi: 10.1351/pac197125010135. [DOI] [PubMed] [Google Scholar]
  13. McNeil M. R., Brennan P. J. Structure, function and biogenesis of the cell envelope of mycobacteria in relation to bacterial physiology, pathogenesis and drug resistance; some thoughts and possibilities arising from recent structural information. Res Microbiol. 1991 May;142(4):451–463. doi: 10.1016/0923-2508(91)90120-y. [DOI] [PubMed] [Google Scholar]
  14. Paulin L. G., Brander E. E., Pösö H. J. Specific inhibition of spermidine synthesis in Mycobacteria spp. by the dextro isomer of ethambutol. Antimicrob Agents Chemother. 1985 Jul;28(1):157–159. doi: 10.1128/aac.28.1.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Silve G., Valero-Guillen P., Quemard A., Dupont M. A., Daffe M., Laneelle G. Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug. Antimicrob Agents Chemother. 1993 Jul;37(7):1536–1538. doi: 10.1128/aac.37.7.1536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Snapper S. B., Melton R. E., Mustafa S., Kieser T., Jacobs W. R., Jr Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol. 1990 Nov;4(11):1911–1919. doi: 10.1111/j.1365-2958.1990.tb02040.x. [DOI] [PubMed] [Google Scholar]
  17. Takayama K., Armstrong E. L., Kunugi K. A., Kilburn J. O. Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob Agents Chemother. 1979 Aug;16(2):240–242. doi: 10.1128/aac.16.2.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Takayama K., Kilburn J. O. Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother. 1989 Sep;33(9):1493–1499. doi: 10.1128/aac.33.9.1493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wheeler P. R., Besra G. S., Minnikin D. E., Ratledge C. Stimulation of mycolic acid biosynthesis by incorporation of cis-tetracos-5-enoic acid in a cell-wall preparation from Mycobacterium smegmatis. Biochim Biophys Acta. 1993 Apr 7;1167(2):182–188. doi: 10.1016/0005-2760(93)90160-b. [DOI] [PubMed] [Google Scholar]
  20. Wolucka B. A., McNeil M. R., de Hoffmann E., Chojnacki T., Brennan P. J. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. J Biol Chem. 1994 Sep 16;269(37):23328–23335. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES